Pres. Trump's deal with Pfizer is pretty devastating to PBMs and insurance companies: John Lamattina

President Trump announcing a deal with Fizer. The drug maker will be selling medication directly to consumers through a new website that's called Trump RX. The company won't face Pharma specific tariffs as long as it invests in US manufacturing.Joining us right now is John Lamatina. He is a senior partner at Pure Tech Health and he's also the author of multiple books on the industry including Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices. He's also the former president of Fizer Global ...